DNMT1, DNMT3A, and DNMT3B are overexpressed across several types of cancer lineages, including acute myeloid leukemia (AML), melanoma, breast cancer, colorectal cancer, prostate cancer, and stomach cancer6–11. Here, DNMT3B is linked to acute myeloid leukemia.